Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
59. Low-Dose Buprenorphine Initiation (Micro-induction)
59. Low-Dose Buprenorphine Initiation (Micro-induction)
59. Low-Dose Buprenorphine Initiation (Micro-induction)
Monday 5th May 2025
Explore low-dose buprenorphine initiation and its impact on addiction treatment in this engaging episode of Addiction Medicine Journal Club.
34 minutes
Informative
Educational
Compassionate
Engaging
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
70 (View all)
Do you want to link to this podcast?
Get the buttons here!Unpacking Low-Dose Buprenorphine: A New Approach
Episode Overview
- Low-dose buprenorphine initiation may reduce precipitated withdrawal risk.
- Ropinerole can cause impulse control disorders like gambling.
- New non-opioid painkiller suzetrigine offers alternative pain management.
- Understanding patient demographics is crucial for treatment success.
- Support systems are vital for outpatient addiction treatment.
"Starting buprenorphine when there are other opioids in the patient's receptors can lead to precipitated withdrawal."
If you're curious about the intricacies of addiction treatment, this episode of Addiction Medicine Journal Club might just be your cup of tea. Dr. John Keenan and Dr. Sonya Del Tredici delve into the outpatient initiation of low-dose buprenorphine, a method that’s gaining traction for its potential to ease the transition for those using fentanyl.
They discuss a recent study published in JAMA Network Open, which evaluates two low-dose initiation protocols and their effectiveness in helping patients start and stick with buprenorphine treatment. But that's not all! The episode also touches on the unexpected consequences of medications like ropinerole, which has been linked to impulse control disorders, leading to behaviours like gambling and compulsive shopping.
This revelation is a wake-up call for doctors prescribing such medications, highlighting the importance of discussing potential side effects with patients. In addition, the hosts chat about a new non-opioid painkiller called suzetrigine, offering hope for those seeking alternatives to traditional pain management methods. The conversation flows naturally with a mix of light-hearted banter about camping trips and gardening, making the complex topics more digestible.
If you're in the medical field or simply interested in the latest developments in addiction treatment, this episode provides valuable insights and real-world applications. Could these protocols change the way we approach addiction treatment? Dive in to find out!